INSERRA, Gaetano
 Distribuzione geografica
Continente #
NA - Nord America 2.330
EU - Europa 1.112
AS - Asia 886
SA - Sud America 205
AF - Africa 118
OC - Oceania 6
Totale 4.657
Nazione #
US - Stati Uniti d'America 2.256
SG - Singapore 502
IT - Italia 353
CN - Cina 283
IE - Irlanda 272
BR - Brasile 196
DE - Germania 151
UA - Ucraina 124
RU - Federazione Russa 84
CA - Canada 66
CI - Costa d'Avorio 66
IN - India 36
SN - Senegal 36
SE - Svezia 26
GB - Regno Unito 25
FR - Francia 23
VN - Vietnam 15
AT - Austria 8
CH - Svizzera 8
IQ - Iraq 8
ZA - Sudafrica 8
BD - Bangladesh 7
FI - Finlandia 7
NL - Olanda 6
AU - Australia 5
BE - Belgio 5
GR - Grecia 5
TR - Turchia 5
UZ - Uzbekistan 5
MX - Messico 4
BA - Bosnia-Erzegovina 3
ET - Etiopia 3
LB - Libano 3
PK - Pakistan 3
PL - Polonia 3
AL - Albania 2
AR - Argentina 2
AZ - Azerbaigian 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
HK - Hong Kong 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
JP - Giappone 2
KR - Corea 2
MA - Marocco 2
NP - Nepal 2
PY - Paraguay 2
SA - Arabia Saudita 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CL - Cile 1
CO - Colombia 1
EE - Estonia 1
GT - Guatemala 1
ID - Indonesia 1
JO - Giordania 1
KE - Kenya 1
MK - Macedonia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RS - Serbia 1
TT - Trinidad e Tobago 1
Totale 4.657
Città #
Santa Clara 445
Chandler 374
Singapore 283
Dublin 272
Houston 158
Jacksonville 146
Chicago 133
Boardman 101
Bremen 77
Lawrence 77
Cambridge 76
Andover 75
Nanjing 67
Abidjan 66
Ashburn 54
Des Moines 48
Toronto 48
Catania 47
Beijing 44
Grafing 43
Civitanova Marche 42
Dakar 36
Wilmington 35
Nanchang 26
Saint Petersburg 23
Council Bluffs 21
San Mateo 19
Shenyang 19
Civitavecchia 16
The Dalles 16
Hebei 14
Kochi 14
Columbus 13
Ottawa 13
Vicenza 13
Jiaxing 12
Moscow 11
São Paulo 11
Tianjin 11
Ann Arbor 10
Changsha 10
Dong Ket 9
Los Angeles 8
Rome 8
Munich 7
Pune 7
San Giuliano Milanese 7
Modena 6
Padova 6
Rio de Janeiro 6
Seattle 6
Aci Catena 5
Brasília 5
Brooklyn 5
Brussels 5
Guangzhou 5
Hefei 5
Jinan 5
Johannesburg 5
Messina 5
Baghdad 4
Belo Horizonte 4
Falls Church 4
Hanoi 4
Helsinki 4
Liberty Lake 4
Ludwigshafen 4
Manzano 4
Milan 4
Porto Alegre 4
Shanghai 4
Washington 4
Zhengzhou 4
Atlanta 3
Bernareggio 3
Campinas 3
Canberra 3
Curitiba 3
Frankfurt am Main 3
Goiânia 3
Guarulhos 3
Huddersfield 3
Lanzhou 3
Marano di Napoli 3
Modica 3
Ningbo 3
Norwalk 3
Oliena 3
Palermo 3
Phoenix 3
Recife 3
Reigate 3
Trecastagni 3
Warsaw 3
Ardabil 2
Baku 2
Barletta 2
Brno 2
Camerata Picena 2
Cape Town 2
Totale 3.261
Nome #
ASSOCIATION OF IRRITABLE BOWEL SYNDROME WITH NON-EROSIVE REFLUX DISEASE 246
Anxiety, depression, chronic inflammation and aortic stiffness in Crohn’s disease: the brain-gut-vascular axis 112
La Fenoverina nel trattamento della sindrome del colon irritabile 109
PREVALENCE OF INFLAMMATORY BOWEL DISEASE IN PATIENTS WITH CELIAC DISEASE IN EASTERN SICILY AREA 105
Can Conventional and Diffusion-Weighted MR Enterography Biomarkers Differentiate Inflammatory from Fibrotic Strictures in Crohn's Disease? 104
Uso della mesalazina e del beclometasone dipropionato nella pancolite ulcerosa. Descrizione di un caso clinico 94
Colorectal Endoscopic Polipectomy: A Retrospective Study 87
Crohn's disease during pregnancy 85
Aortic Stiffness in Patients With Inflammatory Bowel Disease Reduced After Anti-Tumor Necrosis Factor Therapy 85
Pulse wave velocity differs between ulcerative colitis and chronic kidney disease 84
CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRUS (CMV) INFECTION IN INFLAMMATORY BOWEL DISEASE 83
685 Risk Factor Analysis for Therapy Related Adverse Events and Infections in Elder Patients With Inflammatory Bowel Disease; An Analysis From the iG-IBD Aged Study 82
A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients with Crohn's Disease: Real-Life Data from the Sicilian Network for Inflammatory Bowel Disease 82
Arterial stiffness is increased in patients with inflammatory bowel disease 81
Arterial structure and function in inflammatory bowel disease. 80
RISK FACTORS OF COLORECTAL POLYPS IN MALE POPULATION OF SOUTH-EASTERN SICILY 80
Linfoma non-Hodgkin ad esordio digiunale (stadio II E 2). Follow-up a medio termine di un caso trattato con chirurgia e terapia sistemica 79
Caso clinico: Una rettorragia in un giovane ragazzo 79
Gastrointestinal complications after kidney transplantation 78
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions 77
Overlapping of gastroesophageal reflux disease and irritable Bowel syndrome 74
A case of osseous metaplasia in the stomach 71
Irritable Bowel syndrome: subgroups and relationship with gastroesophageal reflux disease 71
Arterial stiffness in inflammatory bowel disease: a systematic review and meta-analysis 70
PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE INCREASED ARTERIAL STIFFNESS 69
Alterazioni carotidee in corso di insufficienza renale cronica 69
Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD “AGED study” 69
Pepsinogen A, Pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics 68
Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study 68
A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis 66
AORTIC-BRACHIAL STIFFNESS MISMATCH STARTS EARLY IN PATIENTS WITH CHRONIC KIDNEY DISEASE 66
Arterial stiffness in patients with inflammatory bowel diseases 65
Combined use of ultrasound and GFR predictive equations for the estimation of renal function in elderly patients 65
Letter: SPOSIB SB2—a Sicilian prospective observational study of IBD patients treated with infliximab biosimilar SB2 64
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis 62
Clinical significance of cytomegalovirus (CMV) infection in inflammatory bowel disease 61
Crohn's disease of the small bowel: evaluation of ileal inflammation by diffusion-weighted MR imaging and correlation with the Harvey-Bradshaw index 60
Protection By Copper (Cu++) Against Ethanol-Induced Gastric Mucosal Injury In The Rat 60
Arterial stiffness is increased in inflammatory bowel disease, dependent upon inflammation and reduced by immunomodulatory drugs 60
Valutazione non invasiva dei baroriflessi e della funzione carotidea nell'insufficienza renale: il sistema echotracking 60
EVALUATION OF CROHN'S DISEASE ACTIVITY BY DIFFUSION-WEIGHTED MAGNETIC RESONANCE IMAGING (MRI) 58
Phenotypic variation of Helicobacter pylori isolates from geographically distinct regions detected by lectin typing 58
La clebopride nel trattamento della dispepsia funzionale: studio clinico in doppio cieco v/s placebo 57
Hiatal Hernia And Reflux Esophagitis: An Endoscopic Study 55
Su1339 Ulcerative Colitis (UC) Diagnosed Over Age 65 Years -An IG-IBD Study 55
Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study 53
PREVALENZA DI HHV6 NELLE MALATTIE INFIAMMATORIE DELL’INTESTINO 53
Subclinical atherosclerosis in patients with inflammatory bowel diseases: A systematic review and meta-analysis 52
COMPARISON OF ESTIMATING GFR FORMULAS IN ELDERLY 51
Inflammation and aortic stiffness: An individual participant data meta-analysis in patients with inflammatory bowel disease 51
Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine. A single-blind randomized controlled trial 50
Increased cardiovascular risk in subjects with a low prevalence of classic cardiovascular risk factors: The inflammatory bowel disease paradox 50
P660. Estimation of cardiovascular risk according to asymptomatic organ damage in subjects with inflammatory bowel disease 49
Prevalenza di HHV6 nelle malattie infiammatorie dell’intestino 48
Inflammation and Aortic Pulse Wave Velocity: A Multicenter Longitudinal Study in Patients With Inflammatory Bowel Disease 48
LEWIS ANTIGEN EXPRESSION AND OTHER PATHOGENIC FACTORS IN THE PRESENCE OF ATROPHIC CHRONIC GASTRITIS IN A EUROPEAN POPULATION 47
Estimated GFR and renal sinus section area are independent predictors of renal dysfunction in elderly 45
P.05.4 ARTERIAL STIFFNESS IS INCREASED IN IBD PATIENTS 45
Increased arterial stiffness in inflammatory bowel diseases is dependent upon inflammation and reduced by immunomodulatory drugs 42
Inflammatory bowel diseases and pericarditis 42
Omeprazole vs. ranitidine in short-term treatment of Helicobacter pylori positive duodenal ulcer patients 40
Patient and physician views on the quality of care in inflammatory bowel disease: Results from SOLUTION-1, a prospective IG-IBD study 40
P181 Diagnostic performance of Diffusion-Weighted Magnetic Resonance Imaging (DW-MRI) in the evaluation of stenosis and endoscopic recurrence in Crohn's disease 39
Patient and physician views on the quality of care for inflammatory bowel disease after one-year follow-up: Results from SOLUTION-2, a prospective IG-IBD study 38
OC.02.3 A REAL LIFE COMPARISON OF THE EFFECTIVENESS OF ADALIMUMAB VERSUS GOLIMUMAB IN MODERATE-TO-SEVERE ULCERATIVE COLITIS. A MULTICENTRE EXPERIENCE FROM A REGIONAL NETWORK FOR INFLAMMATORY BOWEL DISEASE 38
Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 37
P.07.1 ELDERLY PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) ARE LESS LIKELY TO PERSIST ON ANTI-TNF THERAPY COMPARED WITH YOUNGER PATIENTS. DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASES (SN-IBD) 35
OC.02.4 THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD): A COMPARISON OF THE EFFICACY OF CURRENT BIOLOGICS IN CROHN'S DISEASE 35
Early anti-tumor necrosis factor therapy reduces aortic stiffness in inflammatory bowel disease: a multicentre longitudinal study 35
P737 SPOSIB SB2: A Sicilian prospective observational study of patients with inflammatory bowel disease treated with infliximab Biosimilar SB2 (Flixabi®): interim analysis 32
OC.06.2: The Sicilian Network of Biological Therapy in Inflammatory Bowel Disease: Preliminary Data from a Prospective Study on Efficacy and Safety 32
P545 Elderly patients with inflammatory bowel disease (IBD) are less likely to persist on anti-TNF therapy compared with younger patients: data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD) 30
P577 A propensity score-matched comparison of infliximab and adalimumab in naïve and non-naïve patients with Crohn’s disease 30
OC.12.3 SPOSIB SB2 – A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH INFLIXIMAB BIOSIMILAR SB2 (FLIXABI®): INTERIM ANALYSIS 29
Estimation of cardiovascular risk according to asymptomatic organ damage in subjects with inflammatory bowel disease 27
P.05.22 INFLAMMATORY BOWEL DISEASES AND PERICARDITIS 26
P539 Does a change in therapeutic approach modify outcome in IBD patients? A comparison between two cohorts 2004–2007 and 2010–2013 26
P412 The Sicilian network of biological therapy in inflammatory bowel disease: preliminary data on efficacy 26
Totale 4.834
Categoria #
all - tutte 18.069
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.069


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021394 22 27 33 2 102 13 38 7 80 17 33 20
2021/2022540 64 81 4 15 86 5 81 18 34 1 17 134
2022/20231.043 86 67 25 171 81 172 4 176 225 5 25 6
2023/2024367 23 57 21 12 16 66 19 28 3 7 83 32
2024/20251.641 20 233 98 79 354 217 65 64 144 155 114 98
2025/202678 78 0 0 0 0 0 0 0 0 0 0 0
Totale 4.834